$DIVIDENDS INSIGHTS →AbbVie is acquiring Apogee Therapeutics for $10.9 billion, marking its largest acquisition in more than five years and one of the biggest biotech deals of 2026.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →